BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 33955121)

  • 1. Recurrence Outcomes Less Favorable in T1 Rectal Cancer than in T1 Colon Cancer.
    Chang LC; Shun CT; Lin BR; Sanduleanu S; Hsu WF; Wu MS; Chiu HM
    Oncologist; 2021 Sep; 26(9):e1548-e1554. PubMed ID: 33955121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors of recurrence in T1 colorectal cancers treated by endoscopic resection alone or surgical resection with lymph node dissection.
    Kouyama Y; Kudo SE; Miyachi H; Ichimasa K; Matsudaira S; Misawa M; Mori Y; Kudo T; Hayashi T; Wakamura K; Ishida F; Hamatani S
    Int J Colorectal Dis; 2018 Aug; 33(8):1029-1038. PubMed ID: 29748707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver metastases from colon and rectal cancer in terms of differences in their clinical parameters].
    Liška V; Emingr M; Skála M; Pálek R; Troup O; Novák P; Vyčítal O; Skalický T; Třeška V
    Rozhl Chir; 2016 Feb; 95(2):69-77. PubMed ID: 27008168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Comorbidities in Stage II/III Colorectal Cancer Patients Treated With Surgery and Neoadjuvant/Adjuvant Chemotherapy: A Single-Center, Observational Study.
    Baretti M; Rimassa L; Personeni N; Giordano L; Tronconi MC; Pressiani T; Bozzarelli S; Santoro A
    Clin Colorectal Cancer; 2018 Sep; 17(3):e489-e498. PubMed ID: 29650416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study.
    Kobayashi H; Mochizuki H; Morita T; Kotake K; Teramoto T; Kameoka S; Saito Y; Takahashi K; Hase K; Oya M; Maeda K; Hirai T; Kameyama M; Shirouzu K; Sugihara K
    J Gastroenterol; 2011 Feb; 46(2):203-11. PubMed ID: 21152938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of lymph node metastasis in T1 carcinoma of the colon and rectum.
    Nascimbeni R; Burgart LJ; Nivatvongs S; Larson DR
    Dis Colon Rectum; 2002 Feb; 45(2):200-6. PubMed ID: 11852333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term outcomes after resection of para-aortic lymph node metastasis from left-sided colon and rectal cancer.
    Nakai N; Yamaguchi T; Kinugasa Y; Shiomi A; Kagawa H; Yamakawa Y; Numata M; Furutani A
    Int J Colorectal Dis; 2017 Jul; 32(7):999-1007. PubMed ID: 28382511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of residual lateral lymph node metastasis after neoadjuvant (chemo)radiotherapy in patients with advanced low rectal cancer.
    Akiyoshi T; Toda S; Tominaga T; Oba K; Tomizawa K; Hanaoka Y; Nagasaki T; Konishi T; Matoba S; Fukunaga Y; Ueno M; Kuroyanagi H
    BJS Open; 2019 Dec; 3(6):822-829. PubMed ID: 31832589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of metastatic lymph node regression grade after neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer.
    Tominaga T; Akiyoshi T; Yamamoto N; Oba K; Nagasaki T; Yamaguchi T; Konishi T; Fukunaga Y; Ueno M
    Surgery; 2019 Dec; 166(6):1061-1067. PubMed ID: 31345564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphovascular invasion: a comprehensive appraisal in colon and rectal adenocarcinoma.
    Hogan J; Chang KH; Duff G; Samaha G; Kelly N; Burton M; Burton E; Coffey JC
    Dis Colon Rectum; 2015 Jun; 58(6):547-55. PubMed ID: 25944426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T1 adenocarcinoma of the rectum: transanal excision or radical surgery?
    Bentrem DJ; Okabe S; Wong WD; Guillem JG; Weiser MR; Temple LK; Ben-Porat LS; Minsky BD; Cohen AM; Paty PB
    Ann Surg; 2005 Oct; 242(4):472-7; discussion 477-9. PubMed ID: 16192807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival outcome of local excision versus radical resection of colon or rectal carcinoma: a Surveillance, Epidemiology, and End Results (SEER) population-based study.
    Bhangu A; Brown G; Nicholls RJ; Wong J; Darzi A; Tekkis P
    Ann Surg; 2013 Oct; 258(4):563-9; discussion 569-71. PubMed ID: 23979270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymph node metastasis in T1 adenocarcinoma of the colon and rectum.
    Okabe S; Shia J; Nash G; Wong WD; Guillem JG; Weiser MR; Temple L; Sugihara K; Paty PB
    J Gastrointest Surg; 2004 Dec; 8(8):1032-9; discussion 1039-40. PubMed ID: 15585391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
    Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
    [No Abstract]   [Full Text] [Related]  

  • 17. Descriptive characteristics of colon and rectal cancer recurrence in a Danish population-based study.
    Holmes AC; Riis AH; Erichsen R; Fedirko V; Ostenfeld EB; Vyberg M; Thorlacius-Ussing O; Lash TL
    Acta Oncol; 2017 Aug; 56(8):1111-1119. PubMed ID: 28339306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study.
    Nilsson E; Wetterholm E; Syk I; Thorlacius H; Rönnow CF
    BJS Open; 2024 May; 8(3):. PubMed ID: 38869239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of the 12-gene colon cancer recurrence score as a predictor of recurrence risk in stage II and III rectal cancer patients.
    Reimers MS; Kuppen PJ; Lee M; Lopatin M; Tezcan H; Putter H; Clark-Langone K; Liefers GJ; Shak S; van de Velde CJ
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25261968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recurrence risk and prognostic parameters in stage I rectal cancers.
    Cihan S; Kucukoner M; Ozdemir N; Dane F; Sendur MA; Yazilitas D; Urakci Z; Durnali A; Yuksel S; Aksoy S; Colak D; Seker MM; Taskoylu BY; Oguz A; Isikdogan A; Zengin N
    Asian Pac J Cancer Prev; 2014; 15(13):5337-41. PubMed ID: 25040998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.